- Home
- CDNA vs HDL Comparison
CDNA vs HDL Comparison
Compare CDNA & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- HDL
- Stock Information
- Founded
- CDNA 1998
- HDL 2016
- Country
- CDNA United States
- HDL Singapore
- Employees
- CDNA N/A
- HDL N/A
- Industry
- CDNA Medical Specialities
- HDL Restaurants
- Sector
- CDNA Health Care
- HDL Consumer Discretionary
- Exchange
- CDNA Nasdaq
- HDL Nasdaq
- Market Cap
- CDNA 1.1B
- HDL 1.4B
- IPO Year
- CDNA 2014
- HDL 2024
- Fundamental
- Price
- CDNA $22.94
- HDL $24.55
- Analyst Decision
- CDNA Buy
- HDL
- Analyst Count
- CDNA 8
- HDL 0
- Target Price
- CDNA $26.43
- HDL N/A
- AVG Volume (30 Days)
- CDNA 823.5K
- HDL 11.1K
- Earning Date
- CDNA 02-26-2025
- HDL 02-20-2025
- Dividend Yield
- CDNA N/A
- HDL N/A
- EPS Growth
- CDNA N/A
- HDL N/A
- EPS
- CDNA N/A
- HDL 0.09
- Revenue
- CDNA $312,775,000.00
- HDL $759,894,000.00
- Revenue This Year
- CDNA $20.27
- HDL $18.96
- Revenue Next Year
- CDNA $11.76
- HDL $14.25
- P/E Ratio
- CDNA N/A
- HDL $272.51
- Revenue Growth
- CDNA 5.26
- HDL 16.09
- 52 Week Low
- CDNA $7.42
- HDL $13.94
- 52 Week High
- CDNA $34.84
- HDL $30.00
- Technical
- Relative Strength Index (RSI)
- CDNA 53.43
- HDL N/A
- Support Level
- CDNA $21.96
- HDL N/A
- Resistance Level
- CDNA $23.80
- HDL N/A
- Average True Range (ATR)
- CDNA 1.53
- HDL 0.00
- MACD
- CDNA 0.09
- HDL 0.00
- Stochastic Oscillator
- CDNA 45.88
- HDL 0.00
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan.